Evidence-based PET for haematological tumours

Haematological malignancies include lymphomas such as Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), leukaemia and multiple myeloma (MM). They can affect any organ system and positron emission tomography/computed tomography (PET/CT) has been accepted as part of the routine management of most of them. In this chapter were only considered recent systematic reviews and meta-analyses concerning the use of PET or PET/CT with 18F-FDG in haematological malignancies dividing the results by the main areas of application.